Skip to content
value.today

OrisDx Inc.

🇺🇸 Chicago, Illinois, USABiotechnologyFounded 2022
Total raised
$3 M
1 round on record
Latest round
$3 M
May 2025
First round on record
May 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of OrisDx Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2025$3 MNo. 1$2 to $10 million

OrisDx Inc.: Raise no. 1, May 2025

Investors in this round

25 investors had bought by the notice of Jul 16, 2025: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Harald Steltzer · Executive Officer, Director
  • Patrick Conniff · Executive Officer
  • Evgeny Izmchenko · Director
  • Nishant Agrawal · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harald Steltzer, Chief Executive Officer. Newest notice filed Jul 16, 2025. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • OrisDx Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2025).

    SEC Form D · Jul 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of OrisDx Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by OrisDx Inc.
NameRoleNamed in
Harald SteltzerExecutive officerJul 2025
Patrick ConniffExecutive officerJul 2025
Evgeny IzmchenkoDirectorJul 2025
Harald SteltzerDirectorJul 2025
Nishant AgrawalDirectorJul 2025